Ilika steps onto the stage in Detroit

Ilika Plc

Ilika has confirmed it will take part in The Battery Show North America 2025, a major event in the global battery calendar. Running from 6 to 9 October in Detroit, the show brings together over 1,300 exhibitors and attracts more than 21,000 attendees. The conference component alone features upwards of 150 speakers, creating a concentrated forum where new technologies and strategic directions are scrutinised by peers, customers, and potential partners alike.

Denis Pasero, representing the company, is scheduled to deliver a presentation on 8 October at 16:30. His session is titled “Safer Solid State Battery Cells Yield Lighter, Cheaper and more Sustainable Electric Vehicles.”

The Battery Show is known for its scale and breadth, covering advanced batteries, electric vehicle integration, manufacturing processes, and the wider energy storage supply chain.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search